Kadmon

-$0.14 (-1.60%) Today
+$0.03 (+0.35%) As of 9:11 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Kadmon and other ETFs, options, and stocks.

About KDMN

Kadmon Holdings, Inc. is a biopharmaceutical company, which engages in discovering, developing, and commercializing small molecules and biologics to address unmet medical need. The company's clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies.

CEO
Harlan W. Waksal
Employees
127
Headquarters
New York, New York
Founded
2010

KDMN Key Statistics

Market Cap
1.51B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.35M
High Today
$8.75
Low Today
$8.56
Open Price
$8.73
Volume
5.30M
52 Week High
$9.20
52 Week Low
$3.15

KDMN Earnings

-$0.19
-$0.13
-$0.06
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
-$0.18 per share
Actual
-$0.18 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure